Global blood purification equipment market will reach $21.08 billion by 2031, growing by 5.5% annually over 2021-2031, driven by the increasing prevalence of blood-related diseases, rising geriatric population, technological innovations, growing healthcare expenditure, rising adoption of home based healthcare, and the rising health consciousness amid COVID-19 pandemic.
Highlighted with 81 tables and 76 figures, this 154-page report 鈥淕lobal Blood Purification Equipment 麻豆原创 2021-2031 by Product (Hemodialysis, Blood Filtration, CRRT, Hemoperfusion, Plasma Exchange Device), Portability (Portable, Stationary), Indication (Renal Diseases, Sepsis, Others), End User (Hospitals and Clinics, Dialysis Centers, Others), and Region: Trend Forecast and Growth Opportunity鈥� is based on a comprehensive research of the entire global blood purification equipment market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
鈥� 麻豆原创 Structure
鈥� Growth Drivers
鈥� Restraints and Challenges
鈥� Emerging Product Trends & 麻豆原创 Opportunities
鈥� Porter鈥檚 Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global blood purification equipment market in every aspect of the classification from perspectives of Product, Portability, Indication, End User, and Region.
Based on Product, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Hemodialysis Device
鈥� Blood Filtration Device
鈥� CRRT Device
鈥� Hemoperfusion Device
鈥� Plasma Exchange Device
鈥� Other Products
Based on Portability, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Portable Equipment
鈥� Stationary Equipment
Based on Indication, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Renal Diseases
鈥� Sepsis
鈥� Other Indications
Based on End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Hospitals and Clinics
鈥� Dialysis Centers
鈥� Other End Users
Geographically, the following regions together with the listed national/local markets are fully investigated:
鈥� North America (U.S., Canada, and Mexico)
鈥� Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
鈥� APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
鈥� South America (Brazil, Chile, Argentina, Rest of South America)
鈥� MEA (UAE, Saudi Arabia, South Africa, Other Nations)
For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of key national markets by Portability, Indication, and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Aethlon Medical, Inc.
Asahi Kasei Corporation
B. Braun Melsungen AG
Baxter International Inc.
Cerus Corporation
CytoSorbents Corporation
Fresenius SE and Co. KGaA
Healthwell Medical Tech. Co., Ltd.
Infomed SA
Jafron Biomedical Co., Ltd.
Kaneka Corporation
Nikkiso Co., Ltd.
Spectral Medical Inc.
SWS Medical Group
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 8
1.1 Industry Definition and Research Scope 8
1.1.1 Industry Definition 8
1.1.2 Research Scope 9
1.2 Research Methodology 12
1.2.1 Overview of 麻豆原创 Research Methodology 12
1.2.2 麻豆原创 Assumption 13
1.2.3 Secondary Data 13
1.2.4 Primary Data 13
1.2.5 Data Filtration and Model Design 14
1.2.6 麻豆原创 Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17
2 麻豆原创 Overview and Dynamics 19
2.1 麻豆原创 Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the 麻豆原创 22
2.2 Major Growth Drivers 24
2.3 麻豆原创 Restraints and Challenges 31
2.4 Emerging Opportunities and 麻豆原创 Trends 34
2.5 Porter鈥檚 Fiver Forces Analysis 38
3 Segmentation of Global 麻豆原创 by Product 43
3.1 麻豆原创 Overview by Product 43
3.2 Hemodialysis Device 45
3.3 Blood Filtration Device 46
3.4 CRRT Device 47
3.5 Hemoperfusion Device 48
3.6 Plasma Exchange Device 49
3.7 Other Products 50
4 Segmentation of Global 麻豆原创 by Portability 51
4.1 麻豆原创 Overview by Portability 51
4.2 Portable Equipment 53
4.3 Stationary Equipment 54
5 Segmentation of Global 麻豆原创 by Indication 55
5.1 麻豆原创 Overview by Indication 55
5.2 Renal Diseases 57
5.3 Sepsis 58
5.4 Other Indications 59
6 Segmentation of Global 麻豆原创 by End User 60
6.1 麻豆原创 Overview by End User 60
6.2 Hospitals and Clinics 62
6.3 Dialysis Centers 63
6.4 Other End Users 64
7 Segmentation of Global 麻豆原创 by Region 65
7.1 Geographic 麻豆原创 Overview 2021-2031 65
7.2 North America 麻豆原创 2021-2031 by Country 69
7.2.1 Overview of North America 麻豆原创 69
7.2.2 U.S. 73
7.2.3 Canada 76
7.2.4 Mexico 78
7.3 European 麻豆原创 2021-2031 by Country 80
7.3.1 Overview of European 麻豆原创 80
7.3.2 Germany 84
7.3.3 U.K. 86
7.3.4 France 88
7.3.5 Spain 90
7.3.6 Italy 92
7.3.7 Russia 94
7.3.8 Rest of European 麻豆原创 96
7.4 Asia-Pacific 麻豆原创 2021-2031 by Country 98
7.4.1 Overview of Asia-Pacific 麻豆原创 98
7.4.2 Japan 102
7.4.3 China 105
7.4.4 Australia 107
7.4.5 India 109
7.4.6 South Korea 111
7.4.7 Rest of APAC Region 113
7.5 South America 麻豆原创 2021-2031 by Country 115
7.5.1 Argentina 118
7.5.2 Brazil 120
7.5.3 Chile 122
7.5.4 Rest of South America 麻豆原创 124
7.6 MEA 麻豆原创 2021-2031 by Country 125
7.6.1 UAE 128
7.6.2 Saudi Arabia 130
7.6.3 South Africa 132
7.6.4 Other National 麻豆原创s 134
8 Competitive Landscape 135
8.1 Overview of Key Vendors 135
8.2 New Product Launch, Partnership, Investment, and M&A 138
8.3 Company Profiles 139
Aethlon Medical, Inc. 139
Asahi Kasei Corporation 141
B. Braun Melsungen AG 142
Baxter International Inc. 143
Cerus Corporation 144
CytoSorbents Corporation 145
Fresenius SE and Co. KGaA 146
Healthwell Medical Tech. Co., Ltd. 147
Infomed SA 148
Jafron Biomedical Co., Ltd. 149
Kaneka Corporation 150
Nikkiso Co., Ltd. 151
Spectral Medical Inc. 152
SWS Medical Group 153
RELATED REPORTS 154
Selected Key Players:
Aethlon Medical, Inc.
Asahi Kasei Corporation
B. Braun Melsungen AG
Baxter International Inc.
Cerus Corporation
CytoSorbents Corporation
Fresenius SE and Co. KGaA
Healthwell Medical Tech. Co., Ltd.
Infomed SA
Jafron Biomedical Co., Ltd.
Kaneka Corporation
Nikkiso Co., Ltd.
Spectral Medical Inc.
SWS Medical Group
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
听
听
*If Applicable.
